Table 1.
Characteristics of Patients with Sarcoidosis.
| Patient’s characteristics | n=18 |
|---|---|
| Sex (M/F) | 9/9 |
| Mean age at diagnosis of sarcoidosis | 61.9 (26-77) |
| Smoking status | |
| Never | 7 (39%) |
| Current or former | 11 (61%) |
| Diagnostic procedure of sarcoidosis | |
| Clinically | 4 (22%) |
| Pathologically | 14 (78%) |
| Observation period* (years) | 7.9 (0-32) |
| Pathological type of lung cancer | |
| Adenocarcinoma | 9 (50%) |
| Squamous cell carcinoma | 6 (33%) |
| Small cell carcinoma | 2 (11%) |
| Others† | 1 (6%) |
| Distribution of lymphadenopathy | |
| BHL | 1 (6%) |
| BHL+mediastinum | 5 (28%) |
| UHL | 1 (6%) |
| Mediastinum | 6 (33%) |
| UHL+mediastinum | 2 (11%) |
| No swelling | 3 (17%) |
| Treatment of lung cancer | |
| Surgical resection | 11 (61%) |
| Chemotherapy | 5 (28%) |
| Best supportive care | 2 (11%) |
*Observation period means time from diagnosis of sarcoidosis to lung cancer.
†Others mean poorly differentiated adenocarcinoma and squamous cell carcinoma.
M: male, F: female, BHL: bilateral hilar lymphadenopathy, UHL: unilateral hilar lymphadenopathy